» Articles » PMID: 28962995

Novel Tropheryma Species in a Lung Biopsy Sample from a Kidney Transplant Recipient

Overview
Publisher Elsevier
Date 2017 Oct 1
PMID 28962995
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: A kidney transplant recipient with recurrent pleuritis underwent an open lung biopsy, the results of which revealed multiple nodular infiltrates. Grocott and periodic acid-Schiff staining were positive. Fungal and Tropheryma whipplei PCR were, however, negative. Further identification was needed.

Methods: Formalin-fixed, paraffin-embedded (FFPE) extraction was performed using an FFPE extraction kit. T. whipplei was searched for using a real-time PCR targeting the noncoding repeat specific for T. whipplei. Identification of the bacteria in the extract was done using 16S rDNA and 23S rDNA sequencing and BLAST analysis. Internal transcribed spacer PCR was used for fungal DNA identification.

Results: The FFPE extract was negative for fungi and T. whipplei. 16S rDNA sequence analysis of a 1375 bp fragment gave T. whipplei as the best match with 26 mismatches, resulting in only 98% agreement. Sequence analysis of the 23S rDNA gene again gave T. whipplei as the best match, but with only 91% agreement. A pan-Tropheryma 16S rDNA real-time PCR was developed, and both the biopsy sample and a respiratory sample of the patient were strongly positive. The patient received antimicrobial treatment targeting T. whipplei with good clinical outcome.

Conclusions: 16S and 23S rDNA sequencing gave T. whipplei as the best hit, although with limited agreement. These findings suggest that a novel Tropheryma species that lacks the noncoding repeat, most frequently used for molecular detection of Whipple disease, might be the cause of the pulmonary disease. Adaptation of current PCR protocols is warranted in order to detect all Tropheryma species.

Citing Articles

Pulmonary parenchymal involvement caused by .

Zhang W, Xu L Open Med (Wars). 2021; 16(1):843-846.

PMID: 34131590 PMC: 8174119. DOI: 10.1515/med-2021-0297.


Fluorescent in situ hybridization can be used as a complementary assay for the diagnosis of Tropheryma whipplei infection.

Prudent E, Le Guenno G, Jonckheere S, Vankeerberghen A, Lepidi H, Angelakis E Infection. 2018; 47(2):317-321.

PMID: 30368732 DOI: 10.1007/s15010-018-1243-0.